✦ LIBER ✦

Mo-P1:142 Antioxidant enzymes and cardiovascular risk factors in end-stage renal disease

✍ Scribed by Fytili-Kavakiotou, C.A.; Gounari, E.; Zisi, F.; Daskalaki, M.; Hatzikallinikidou, E.; Progia, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular risk in diabetic end-stag

✍ Angela Yee-Moon WANG 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Complement factor H gene polymorphism an

✍ Monika Buraczynska; Piotr Ksiazek; Pawel Zukowski; Ewa Benedyk-Lorens; Grazyna O 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Traditional and non-traditional risk fac

✍ Yao, Qiang; Pecoits-Filho, Roberto; Lindholm, Bengt; Stenvinkel, Peter 📂 Article 📅 2004 🏛 Informa plc 🌐 English ⚖ 190 KB

Arterial Calcifications, Arterial Stiffn

✍ Blacher, J.; Guerin, A. P.; Pannier, B.; Marchais, S. J.; London, G. M. 📂 Article 📅 2001 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 319 KB

Are traditional risk factors valid for a

✍ DIBYA S SHAH; KEVAN R POLKINGHORNE; REBECCA PELLICANO; PETER G KERR 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB

Sexual Dysfunction and Associated Risk F

✍ Elife Kettaş; Filiz Çayan; Erdem Akbay; Ahmet Kıykım; Selahittin Çayan 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB